Saturday 17 October 2026 Export AMTX’s income statement to Excel — free account

Aemetis, Inc

AMTX Basic Materials Specialty Chemicals

In the quarter to June 2026, revenue grew 20.0%, EPS grew 68.3%, free cash flow fell 12.5% and total debt rose 13.7%, each against the same quarter a year earlier.

1.47 0.02 +1.38%

Follow AMTX

Alert me

Market cap: $104.3M
P/E: 0.0×
Fwd P/E: −2.1×
Dividend yield: —
F-score: 4/9
Altman Z: −4.62
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total sells 0.02

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	—	—	—	—	—	—	—	1	—	—	—	—

Insider Ownership 5.25%

Capital & Financial Ratios $m

Market Cap 104.28

Revenue 230.17

Net Income (60.16)

Free Cash Flow (39.33)

Net Debt 364.16

Current Ratio 0.08

Debt/Equity (1.13)

P/E ratio 0.00

Fwd P/E (2.11)

P/S ratio 0.45

P/B ratio 0.00

Past 5Y EPS Growth —

This Y EPS Growth 31.53%

Next Y EPS Growth 45.09%

Next Y revenue growth 24.87%

Next 5Y EPS Growth 35.09%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/S against its own 10 years 55.92%

10-year low 10-year high

EV/Sales against its own 10 years 67.86%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2025	Powerpack
2024	Powerpack
2023	Powerpack
2022	Powerpack
2021	Powerpack
2020	Powerpack
2019	Powerpack
2017	Powerpack

predictions special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	3	1	5	1
Receivables	9	14	0	14
Inventory	18	25	12	14
Other	3	2	8	2
	36	45	27	33

	2023	2024	2025	Q'26
Payables	32	33	23	31
ST’ Debt	14	64	279	303
Other	15	20	30	30
	84	144	371	415

Compound Annual Growth %

	10y	5y	3y
Sales	3.56%	4.67%	(6.75%)
Cash Flow	0.00%	5.64%	0.00%
Earnings	0.00%	0.00%	0.00%
Book Value	0.00%	0.00%	0.00%

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	55	63	—	—	—
’25	43	52	59	54	208
’24	73	67	81	47	268
’23	2	45	69	71	187
’22	52	66	72	67	257
’21	43	55	50	64	212
’20	39	48	41	37	166

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(11)	(2)	—	—	—
’25	0	(6)	3	6	3
’24	(10)	(5)	(5)	(13)	(33)
’23	(11)	(3)	(6)	34	14
’22	(8)	2	(10)	(7)	(23)
’21	(14)	(4)	(2)	(1)	(21)
’20	1	4	2	(5)	2

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(17)	(10)	—	—	—
’25	(2)	(9)	(1)	(11)	(23)
’24	(14)	(10)	(9)	(19)	(53)
’23	(19)	(5)	(15)	19	(19)
’22	(18)	(11)	(16)	(17)	(62)
’21	(21)	(11)	(8)	(9)	(47)
’20	(2)	(2)	(4)	(9)	(17)

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	(0.33)	(0.13)	—	—	—
’25	(0.47)	(0.41)	(0.37)	(0.08)	(1.28)
’24	(0.58)	(0.66)	(0.38)	(0.36)	(1.91)
’23	(0.73)	(0.68)	0.73	(0.64)	(1.22)
’22	(0.54)	(0.01)	(2.01)	(0.63)	(3.12)
’21	(0.69)	(0.34)	(0.55)	(0.03)	(1.54)
’20	(0.58)	0.10	(0.59)	(0.68)	(1.74)

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	0.38	0.51	0.42	0.59	0.37	2.54	3.71	1.16	2.10	1.22	Analyst estimates 2026–2028 Powerpack
	High	2.60	2.50	3.12	1.70	5.10	27.44	16.06	8.99	7.03	3.66
People
People	Employees	144	140	166	160	164	158	168	205	223	220
	Revenue/emp, $m	0.99	1.07	1.03	1.26	1.01	1.34	1.53	0.91	1.20	0.95
Income, $m
Income, $m	Revenue	143	150	172	202	166	212	257	187	268	208
	Gross margin, %	8.10	2.25	3.15	6.29	6.66	3.75	(2.16)	1.08	(0.22)	(0.37)
	EBT	(16)	(32)	(36)	(38)	(38)	(47)	(107)	(100)	(98)	(96)
	EBT margin, %	(10.92)	(21.15)	(21.15)	(18.98)	(22.73)	(22.30)	(41.60)	(53.64)	(36.75)	(46.04)
	Net income	(16)	(32)	(36)	(39)	(37)	(47)	(108)	(46)	(88)	(77)
	Depreciation	11	10	13	9	8	9	13	14	15	16
Per share, $
Per share, $	Revenue	7.24	7.57	8.47	9.87	7.88	6.91	7.42	4.91	5.83	3.47
	Earnings	(0.79)	(1.53)	(1.63)	(1.75)	(1.74)	(1.54)	(3.12)	(1.22)	(1.91)	(1.28)
	Cash flow	0.02	(0.44)	(0.27)	(0.10)	0.12	(0.67)	(0.66)	0.36	(0.72)	0.05
	Capex	(0.03)	(0.06)	(0.20)	(0.42)	(0.92)	(0.87)	(1.13)	(0.87)	(0.44)	(0.43)
	Free cash flow	(0.01)	(0.49)	(0.47)	(0.52)	(0.80)	(1.54)	(1.79)	(0.51)	(1.16)	(0.38)
	Book value	(2.52)	(4.03)	(5.71)	(7.54)	(8.79)	(3.92)	(5.84)	(5.70)	(5.75)	(5.12)
	Shares, m	20	20	20	20	21	31	35	38	46	60
Valuation, ×
Valuation, ×	P/E	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	P/S	0.21	0.08	0.07	0.08	0.32	1.78	0.53	0.97	0.46	0.40
	P/B	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	EV/Sales	0.92	1.01	1.00	1.00	1.61	2.57	1.33	2.41	1.62	2.03
	EV/FCF	(508.89)	(15.43)	(17.89)	(19.02)	(15.82)	(11.50)	(5.48)	(23.35)	(8.16)	(18.54)
Cash, $m
Cash, $m	Operating cash flow	0	(9)	(6)	(2)	2	(21)	(23)	14	(33)	3
	Capex	(1)	(1)	(4)	(9)	(19)	(27)	(39)	(33)	(20)	(26)
	Free cash flow	0	(10)	(10)	(11)	(17)	(47)	(62)	(19)	(53)	(23)
Balance, $m
Balance, $m	Working capital	(20)	(25)	(32)	(45)	(94)	(45)	(70)	(48)	(99)	(344)
	Total debt	102	140	160	185	215	174	209	271	311	343
	Net debt	101	140	159	185	214	166	205	269	310	338
	Shareholders’ equity	(50)	(80)	(116)	(154)	(185)	(120)	(202)	(217)	(264)	(307)
Returns, %
Returns, %	ROA	(19.43)	(35.20)	(35.47)	(37.26)	(32.58)	(32.97)	(58.57)	(20.61)	(34.83)	(29.66)
	ROIC	(0.96)	(12.71)	(15.72)	(10.12)	(12.76)	(21.41)	(647.80)	(45.27)	(54.39)	(74.29)
	ROE	36.74	46.73	33.79	26.46	21.62	30.92	66.91	22.17	36.41	26.98

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
GEVO Gevo, Inc.	$289.3M	— (loss-making)	— (loss-making)	+7.11% (above 0%: growing)	n/m	−167.47% (below 0%: shrinking)	42.58%	(369.25%)	Compare
ALTO Alto Ingredients, Inc.	$283.9M	5.0×	12.8×	+12.48% (above 0%: growing)	n/m	+1,443.92% (above 0%: growing)	6.77%	3.51%	Compare
FF FutureFuel Corp.	$247.8M	— (loss-making)	— (loss-making)	+120.69% (above 0%: growing)	n/m	+4,245.38% (above 0%: growing)	19.08%	14.29%	Compare
HDSN Hudson Technologies, Inc.	$212.1M	24.1×	14.1×	+7.54% (above 0%: growing)	−47.83% (below 0%: shrinking)	+5.45% (above 0%: growing)	26.41%	9.44%	Compare
CMT Core Molding Technologies Inc	$206.6M	26.6×	21.6×	−20.84% (below 0%: shrinking)	−55.32% (below 0%: shrinking)	+809.20% (above 0%: growing)	20.29%	3.66%	Compare
FEAM 5E Advanced Materials, Inc.	$156.8M	— (loss-making)	—	—	n/m	+17.79% (above 0%: growing)	0.00%	0.00%	Compare
AMTX Aemetis, Inc	$104.3M	— (loss-making)	— (loss-making)	+20.02% (above 0%: growing)	n/m	−12.47% (below 0%: shrinking)	21.56%	9.21%
NTIC Northern Technologies International Corporation	$73.2M	— (loss-making)	88.9×	+12.59% (above 0%: growing)	n/m	+327.52% (above 0%: growing)	33.63%	2.13%	Compare
CITR CitroTech Inc.	$68.2M	— (loss-making)	—	−59.18% (below 0%: shrinking)	n/m	−30.95% (below 0%: shrinking)	3.21%	(1,244.78%)	Compare
Median of peers	$209.4M	24.1×	17.9×	+7.54%	—	+172.66%	19.69%	2.82%

All 60 Specialty Chemicals stocks →

Aemetis, Inc (AMTX) key facts

Aemetis, Inc (AMTX) is a Specialty Chemicals company in the Basic Materials sector, listed on Nasdaq.
As of October 16, 2026, AMTX traded at $1.47, a market capitalization of $104.3 million.
Return on equity was 27.0% and debt-to-equity -1.13.
Its Piotroski F-score is 4 out of 9 and its Altman Z-score is −4.62 (distress zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.